Status:
RECRUITING
Effects of Probiotics (BioKid LR - Contains Nine Different Species of Probiotics Bacteria Including L. Reuteri) in Children With Functional Constipation
Lead Sponsor:
Ferass Abu Hanna
Collaborating Sponsors:
Ambrosia - SupHerb Ltd.
Conditions:
Constipation
Eligibility:
All Genders
6-17 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to evaluate whether a probiotic supplement, BioKid LR®, can help maintain normal bowel movements after stopping laxative treatment (PEG 3350) in children aged 6 mont...
Eligibility Criteria
Inclusion
- Age 0.5 - 17 years
- Diagnosis of FC based on Rome IV criteria
Exclusion
- Children with chronic diseases which could cause constipation: Celiac disease, food allergy, Hypothyroidism, Inflammatory Bowel Disease, electrolytes disturbances, Cystic fibrosis, Hirschsprung disease, Neuropathic conditions (Spinal cord trauma, Neurofibromatosis, Tethered cord) or intestinal pseudo-obstruction
- Prematurity (\<34 weeks)
- S/P intestinal surgery
- Immunodeficiency
- Malignancy
- Children treated with medications associated with constipation. \*
Key Trial Info
Start Date :
August 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06959758
Start Date
August 6 2024
End Date
August 1 2027
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emek Medical Center
Afula, Israel